Cargando…

Impact of the SARS-coV2 pandemic on patients with multiple sclerosis: A Tunisian study

Detalles Bibliográficos
Autores principales:	Naguez, Mouna, Younes, Samia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498427/ http://dx.doi.org/10.1016/j.jns.2021.118210

Ejemplares similares

Detection of Enteroviruses and SARS-CoV-2 in Tunisian Wastewater
por: Ibrahim, Chourouk, et al.
Publicado: (2023)

The Impact of SARS-CoV-2 Infection on the Development of Neurodegeneration in Multiple Sclerosis
por: Dziedzic, Angela, et al.
Publicado: (2021)

Sars-CoV2 pandemic and lockdown reported consequences on people with multiple sclerosis
por: Sartori, Arianna, et al.
Publicado: (2021)

Multiple sclerosis following SARS-CoV-2 infection
por: Palao, M., et al.
Publicado: (2020)

SARS-CoV-2 triggered relapse of multiple sclerosis
por: Finsterer, Josef
Publicado: (2022)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
por: Woopen, Christina, et al.
Publicado: (2021)

SARS-CoV-2 infection and seroprevalence in patients with multiple sclerosis()
por: Piñar Morales, R., et al.
Publicado: (2021)

Quality of sleep in Tunisian patients with Multiple Sclerosis during the COVID-19 pandemic
por: Safa, K., et al.
Publicado: (2022)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

SARS-CoV-2 Infection and Risk Management in Multiple Sclerosis
por: Diaz de la Fe, Amado, et al.
Publicado: (2021)

SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
por: MacDougall, Madison, et al.
Publicado: (2022)

The Impact of SARS-CoV-2 Infection in Unvaccinated Multiple Sclerosis Patients on Disease-Modifying Therapies
por: Al-Shammri, Suhail, et al.
Publicado: (2023)

Vaccination willingness in association with personality traits in patients with multiple sclerosis in the course of SARS-CoV-2 pandemic
por: Heidler, Felicita, et al.
Publicado: (2022)

Multiple sclerosis treatment blunts SARS-CoV-2 antibody response
por: Lemprière, Sarah
Publicado: (2021)

Could SARS-CoV-2 herald a surge of multiple sclerosis?
por: Shalaby, Nevin Mohieldin, et al.
Publicado: (2021)

Establishment of a safety protocol for the administration of treatments in multiple sclerosis during the SARS-CoV-2 pandemic
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Reactivation of SARS-CoV-2 after Rituximab in a Patient with Multiple Sclerosis
por: Bose, Gauruv, et al.
Publicado: (2021)

Impact of Sars‐CoV‐2 pandemic on psoriatic patients
por: Biondi, Gabriele, et al.
Publicado: (2022)

Acute arthritis following SARS‐CoV‐2 infection: About two cases
por: Brahem, Mouna, et al.
Publicado: (2023)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020)

Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Standl, Fabian, et al.
Publicado: (2021)

Impact of Disease-Modifying Treatments of Multiple Sclerosis on Anti–SARS-CoV-2 Antibodies: An Observational Study
por: Bigaut, Kévin, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg
por: Capasso, Nicola, et al.
Publicado: (2020)

Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies
por: Sellner, Johann, et al.
Publicado: (2021)

Prevalence of SARS-CoV-2 antibodies in multiple sclerosis: The hidden part of the iceberg
por: Capasso, Nicola, et al.
Publicado: (2021)

Clinical Onset and Multiple Sclerosis Relapse after SARS-CoV-2 Infection
por: Pignolo, Antonia, et al.
Publicado: (2021)

SARS-CoV-2 vaccines tolerability: A perspective by people with multiple sclerosis
por: Di Filippo, Massimiliano, et al.
Publicado: (2022)

Impact of SARS‐CoV‐2 on multiple gestation pregnancy
por: Mahajan, Niraj N., et al.
Publicado: (2020)

Evaluation of the MAScIR SARS-CoV-2 M Kit 2.0 on the SARS-CoV-2 Infection
por: Zouaki, Amal, et al.
Publicado: (2023)

Asymptomatic SARS-CoV-2 infection in two patients with multiple sclerosis treated with fingolimod
por: Mallucci, Giulia, et al.
Publicado: (2020)

Vaccine Hesitancy in Patients With Multiple Sclerosis: Preparing for the SARS-CoV-2 Vaccination Challenge
por: Diem, Lara, et al.
Publicado: (2021)

Prolonged SARS-CoV-2 Illness in a Patient Receiving Ocrelizumab for Multiple Sclerosis
por: Gibson, Elena G, et al.
Publicado: (2021)

Response to SARS-CoV-2 vaccination in multiple sclerosis patients on disease modifying therapies
por: Allman, M., et al.
Publicado: (2022)

Impact of SARS-CoV-2 Pandemic on Patients with Primary Immunodeficiency
por: Delavari, Samaneh, et al.
Publicado: (2020)

Whole genome sequencing and phylogenetic classification of Tunisian SARS-CoV-2 strains from patients of the Military Hospital in Tunis
por: Handrick, Susann, et al.
Publicado: (2020)

Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
por: Sabatino, Joseph J., et al.
Publicado: (2021)

Telemedicine for routinary multiple sclerosis follow-up during SARS-CoV2 pandemic: A single center experience
por: Sartori, Arianna, et al.
Publicado: (2021)

Disease-modifying therapies and SARS-CoV-2 vaccination in multiple sclerosis: an expert consensus
por: Centonze, Diego, et al.
Publicado: (2021)

Long term persistence of SARS-CoV-2 humoral response in multiple sclerosis subjects
por: Maniscalco, Giorgia Teresa, et al.
Publicado: (2022)

SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry
por: Arrambide, Georgina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_j6tq25j9a6f8u8d03nf584qq34